Real Heart (HEART) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.026x

Based on the latest financial reports, Real Heart (HEART) has a cash flow conversion efficiency ratio of -0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.94 Million ≈ $-208.80K USD) by net assets (Skr74.35 Million ≈ $8.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Real Heart - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Real Heart's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read HEART liabilities breakdown for a breakdown of total debt and financial obligations.

Real Heart Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Real Heart ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
P3 Health Partners Inc NASDAQ:PIII	-0.814x
Perfect Moment Ltd. NYSE MKT:PMNT	2.134x
Entero Therapeutics, Inc. NASDAQ:ENTO	-0.010x
Titan Logix Corp. V:TLA	-0.030x
Akkhie Prakarn Public Company Limited BK:AKP	0.046x
CD Private Equity Fund I AU:CD1	-0.009x
Thai Wire Products Public Company Limited BK:TWP	-0.050x
Jaya Trishindo Tbk PT JK:HELI	0.022x

Annual Cash Flow Conversion Efficiency for Real Heart (2014–2024)

The table below shows the annual cash flow conversion efficiency of Real Heart from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see HEART company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr67.34 Million ≈ $7.25 Million	Skr-12.99 Million ≈ $-1.40 Million	-0.193x	+36.81%
2023-12-31	Skr82.04 Million ≈ $8.83 Million	Skr-25.05 Million ≈ $-2.70 Million	-0.305x	-304.00%
2022-12-31	Skr97.65 Million ≈ $10.51 Million	Skr-7.38 Million ≈ $-794.22K	-0.076x	+12.86%
2021-12-31	Skr111.29 Million ≈ $11.98 Million	Skr-9.65 Million ≈ $-1.04 Million	-0.087x	+33.92%
2020-12-31	Skr71.69 Million ≈ $7.72 Million	Skr-9.41 Million ≈ $-1.01 Million	-0.131x	-5.77%
2019-12-31	Skr59.00 Million ≈ $6.35 Million	Skr-7.32 Million ≈ $-788.00K	-0.124x	+62.85%
2018-12-31	Skr19.30 Million ≈ $2.08 Million	Skr-6.45 Million ≈ $-693.86K	-0.334x	+6.75%
2017-12-31	Skr27.52 Million ≈ $2.96 Million	Skr-9.86 Million ≈ $-1.06 Million	-0.358x	-66.32%
2016-12-31	Skr16.20 Million ≈ $1.74 Million	Skr-3.49 Million ≈ $-375.55K	-0.215x	+8.16%
2015-12-31	Skr5.97 Million ≈ $642.14K	Skr-1.40 Million ≈ $-150.60K	-0.235x	+0.45%
2014-12-31	Skr7.50 Million ≈ $806.85K	Skr-1.77 Million ≈ $-190.08K	-0.236x	--

About Real Heart

ST:HEART Sweden Medical Devices

Market Cap

$9.58 Million

Skr88.98 Million SEK

Market Cap Rank

#26978 Global

#591 in Sweden

Share Price

Skr17.80

Change (1 day)

-1.66%

52-Week Range

Skr12.85 - Skr29.00

All Time High

Skr1625.78